Published in Vaccine Weekly, September 13th, 1999
This is a complementary approach for exploring immunogenic mechanisms of potential vaccine candidates such as Plasmodium falciparum antigens in humans, reported Institut Pasteur researcher O. Garraud and colleagues ("Immune Responses to Plasmodium falciparum-Merozoite Surface Protein 1 (MSP1) Antigen, II. Induction of Parasite-Specific Immunoglobulin G in Unsensitized Human B Cells after in vitro T-Cell Priming with MSP119 ," Immunology, 1999;97(3):497-505).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly